Delivery Order SPE2DR25D1017-SPE2DR26F9CMK
- Not listed
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits under a firm fixed-price contract. The order, issued on December 31, 2025, with completion targeted for January 23, 2026, represents a non-set-aside competitive award to support federal medical procurement requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a contract ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a ceiling value of $1,584.52. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of September 25, 2025. This competitive delivery order represents a firm fixed price transaction with no set-aside designation. The award was made on September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,240.82 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen kits. The contract, issued on January 2, 2026, with an ultimate completion date of January 26, 2026, is a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a competitive procurement under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits under a firm fixed-price contract with a ceiling value of $2,911.28. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,676.16 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This competitive contract represents a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for Zymfentra 120 mg/ml pen kits, with performance completion targeted for January 21, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the vendor's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 26, 2025, for Zymfentra 120 mg/ml pen kits valued at $3,007.12. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of October 20, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CMKDelivery Order
The Defense Logistics Agency awarded a $4,240.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 26, 2026. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems across multiple therapeutic domains. The delivery order is issued under AmerisourceBergen's prime indefinite delivery vehicle, which enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract structure allows the company to serve multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, with the flexibility to fulfill diverse medical supply requirements. The award demonstrates AmerisourceBergen's capability to meet federal procurement standards through competitive procurement processes and its established role as a preferred vendor for pharmaceutical distribution to Department of Defense medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 1/1/26 |